Research Portfolio

We have been funding research since 2012. Explore our timeline of research projects below, or browse our Current or Completed project pages.

Key

Gene therapy and Gene editing

Cell therapy

Drug therapy

Protein therapy

EB cancer therapy

Research

2016

Lenticol F

Phase I study of lentiviral-mediated COL7A1 gene-modified autologous fibroblasts in adults with Recessive Dystrophic Epidermolysis Bullosa

Read more

ADSTEM

A phase I/II study to evaluate allogeneic mesenchymal stromal cells for the treatment of skin disease in adults with Recessive Dystrophic Epidermolysis Bullosa

Read more

2015

Limbal stem cells

Limbal stem cells for treatment of corneal wounds in Epidermolysis Bullosa

Read more

2014

TALEN-based gene editing

A TALEN-based approach to developing safer, more effective treatments for people with Epidermolysis Bullosa

Read more

2013

EBSTEM

Clinical trial of mesenchymal stromal cells in Recessive Dystrophic Epidermolysis Bullosa

Read more